EGFR and lung adenocarcinoma: This study aims to compare the prevalence of EGFR mutation status in bronchoalveolar lavage samples with the prevalence in peripheral blood, referring to the gold standard—tissue biopsy, in patients with primary lung adenocarcinoma.